• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Rapidly progressive alopecia areata totalis in a COVID-19 patient, unresponsive to tofacitinib.

作者信息

Berbert Ferreira S, Gavazzoni Dias M F R, Berbert Ferreira R, Neves Neto A C, Trüeb R M, Lupi O

机构信息

Private Dermatologic Clinic, Maringá, Brazil.

CEPED - Centro Paranaense de Estudos em Dermatologia, Maringá, Brazil.

出版信息

J Eur Acad Dermatol Venereol. 2021 Jul;35(7):e411-e412. doi: 10.1111/jdv.17170. Epub 2021 Mar 20.

DOI:10.1111/jdv.17170
PMID:33587766
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8013294/
Abstract
摘要

相似文献

1
Rapidly progressive alopecia areata totalis in a COVID-19 patient, unresponsive to tofacitinib.一名新冠病毒肺炎患者出现快速进展的全秃性斑秃，对托法替布无反应。
J Eur Acad Dermatol Venereol. 2021 Jul;35(7):e411-e412. doi: 10.1111/jdv.17170. Epub 2021 Mar 20.
2
Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients.托法替尼治疗严重斑秃及其变异型：90 例患者研究。
J Am Acad Dermatol. 2017 Jan;76(1):22-28. doi: 10.1016/j.jaad.2016.09.007. Epub 2016 Nov 2.
3
Treatment of Alopecia Areata With Tofacitinib.他卡西醇治疗斑秃。
JAMA Dermatol. 2017 Jun 1;153(6):600-602. doi: 10.1001/jamadermatol.2017.0001.
4
Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers.用托法替布治疗斑秃患者可导致毛发再生以及血清和皮肤生物标志物的变化。
Exp Dermatol. 2016 Aug;25(8):642-3. doi: 10.1111/exd.13060.
5
Successful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib.口服或外用托法替布成功治疗重度斑秃
J Drugs Dermatol. 2018 Jul 1;17(7):800-803.
6
Tofacitinib therapy for children with severe alopecia areata.托法替布治疗儿童重度斑秃
J Am Acad Dermatol. 2019 Apr;80(4):1164-1166. doi: 10.1016/j.jaad.2018.12.041. Epub 2019 Jan 8.
7
Topical tofacitinib in treatment of alopecia areata.局部应用托法替布治疗斑秃。
Einstein (Sao Paulo). 2020;18:eAI5452. doi: 10.31744/einstein_journal/2020ai5452. Epub 2020 Aug 10.
8
Treatment outcome of oral tofacitinib and ruxolitinib in patients with alopecia areata: A systematic review and meta-analysis.斑秃患者口服托法替尼和芦可替尼治疗结局的系统评价和荟萃分析。
Indian J Dermatol Venereol Leprol. 2021 Sep-Oct;87(5):621-627. doi: 10.25259/IJDVL_975_19.
9
Tofacitinib for the Treatment of Three Immune-mediated Conditions in One Patient: Ulcerative Colitis, Pyoderma Gangrenosum, and Alopecia Areata.托法替布用于治疗一名患者的三种免疫介导疾病：溃疡性结肠炎、坏疽性脓皮病和斑秃。
Inflamm Bowel Dis. 2021 Apr 15;27(5):e65. doi: 10.1093/ibd/izab005.
10
Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study.Janus 激酶抑制剂治疗严重斑秃：一项开放性比较研究。
Dermatology. 2019;235(2):130-136. doi: 10.1159/000494613. Epub 2018 Dec 19.

引用本文的文献

1
The correlation between corona virus disease 2019 and alopecia areata: a literature review.新型冠状病毒病 2019 与斑秃的相关性：文献综述。
Front Immunol. 2024 Jul 3;15:1347311. doi: 10.3389/fimmu.2024.1347311. eCollection 2024.
2
Viral-Induced Rapidly Progressive Alopecia Universalis: A Case Report and Literature Review.病毒诱导的泛发性快速进展性脱发：一例报告及文献综述
Cureus. 2023 Apr 10;15(4):e37406. doi: 10.7759/cureus.37406. eCollection 2023 Apr.
3
COVID-19 and the potential of Janus family kinase (JAK) pathway inhibition: A novel treatment strategy.2019冠状病毒病与 Janus 激酶（JAK）通路抑制的潜力：一种新的治疗策略。
Front Med (Lausanne). 2022 Aug 30;9:961027. doi: 10.3389/fmed.2022.961027. eCollection 2022.
4
Not just thinning: A case of alopecia universalis after mild COVID-19.不仅仅是头发稀疏：一例轻症新冠病毒感染后的全秃病例。
JAAD Case Rep. 2022 Jul;25:1-3. doi: 10.1016/j.jdcr.2022.04.024. Epub 2022 May 7.
5
The role of SARS-CoV-2 infection and its vaccines in various types of hair loss.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染及其疫苗在各类脱发中的作用
Dermatol Ther. 2022 Jun;35(6):e15433. doi: 10.1111/dth.15433. Epub 2022 Apr 1.
6
Alopecia in patients with COVID-19: A systematic review and meta-analysis.新型冠状病毒肺炎患者的脱发：一项系统评价与荟萃分析
JAAD Int. 2022 Jun;7:67-77. doi: 10.1016/j.jdin.2022.02.006. Epub 2022 Feb 22.
7
Alopecia areata after COVID-19 vaccination.新冠疫苗接种后出现斑秃。
Clin Exp Vaccine Res. 2022 Jan;11(1):129-132. doi: 10.7774/cevr.2022.11.1.129. Epub 2022 Jan 31.
8
Association between alopecia areata and COVID-19: A systematic review.斑秃与2019冠状病毒病之间的关联：一项系统评价。
JAAD Int. 2022 Jun;7:57-61. doi: 10.1016/j.jdin.2022.02.002. Epub 2022 Feb 10.
9
Lack of Evidence of COVID-19 Being a Risk Factor of Alopecia Areata: Results of a National Cohort Study in South Korea.缺乏新冠病毒是斑秃风险因素的证据：韩国一项全国队列研究的结果
Front Med (Lausanne). 2021 Oct 13;8:758069. doi: 10.3389/fmed.2021.758069. eCollection 2021.
10
Mild-to-moderate COVID-19 is not associated with worsening of alopecia areata: A retrospective analysis of 32 patients.轻度至中度新冠病毒病与斑秃病情恶化无关：32例患者的回顾性分析
J Am Acad Dermatol. 2021 Sep;85(3):723-725. doi: 10.1016/j.jaad.2021.05.020. Epub 2021 May 26.